Normal prostate-derived stromal cells stimulate prostate cancer development

Cancer Science

Volumn 102, Issue 9, 2011, Pages 1630-1635

  Peng, Yu Bing ^a   Zhou, Juan ^a   Gao, Yan ^b   Li, Yu Hua ^c   Wang, Hao ^a   Zhang, Ming ^a   Ma, Li Ming ^a   Chen, Qi ^a   Da, Jun ^a   Wang, Zhong ^a   Li, Runsheng ^c  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI INSTITUTE OF PLANNED PARENTHOOD RESEARCH   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CYTOSOLIC PHOSPHOENOLPYRUVATE CARBOXYKINASE 1; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45A; GUANOSINE TRIPHOSPHATASE; KALLIKREIN; KALLIKREIN 11; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROTEIN RHOV; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CASTRATION; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DNA MICROARRAY; FIBROBLAST; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOGENESIS; PROSTATE DERIVED STROMAL CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; STROMA CELL; TUMOR MODEL; TUMOR XENOGRAFT;

ANIMALS; CELL COMMUNICATION; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION PROFILING; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; PROSTATE; PROSTATIC NEOPLASMS; STROMAL CELLS;

EID: 80051812014     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.02008.x     Document Type: Article

References (24)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin 2010; 60: 277-300.
2. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988; 12: 897-906.
3. Ruizeveld de Winter JA, Janssen PJ, Sleddens HM et al. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am J Pathol 1994; 144: 735-46.
4. Pienta KJ, Bradley D. Mechanisms underlying the development of androgen-independent prostate cancer. Clin Cancer Res 2006; 12: 1665-71.
5. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003; 349: 366-81.
6. Bhowmick NA, Moses HL. Tumor-stroma interactions. Curr Opin Genet Dev 2005; 15: 97-101.
7. Hu M, Polyak K. Microenvironmental regulation of cancer development. Curr Opin Genet Dev 2008; 18: 27-34.
8. Alberti C. Prostate cancer progression and surrounding microenvironment. Int J Biol Markers 2006; 21: 88-95.
9. Condon MS. The role of the stromal microenvironment in prostate cancer. Semin Cancer Biol 2005; 15: 132-7.
10. Ramirez P, Del Razo LM, Gutierrez-Ruiz MC, Gonsebatt ME. Arsenite induces DNA-protein crosslinks and cytokeratin expression in the WRL-68 human hepatic cell line. Carcinogenesis 2000; 21: 701-6.
11. Bright RK, Vocke CD, Emmert-Buck MR et al. Generation and genetic characterization of immortal human prostate epithelial cell lines derived from primary cancer specimens. Cancer Res 1997; 57: 995-1002.
12. Zhou W, Grandis JR, Wells A. STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines. Br J Cancer 2006; 95: 164-71.
13. Dussault AA, Pouliot M. Rapid and simple comparison of messenger RNA levels using real-time PCR. Biol Proced Online 2006; 8: 1-10.
14. McNeal JE. The zonal anatomy of the prostate. Prostate 1981; 2: 35-49.
15. Quiles MT, Arbós MA, Fraga A, de Torres IM, Reventós J, Morote J. Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH). Prostate 2010; 70: 1044-53.
16. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182: 311-22.
17. Tuxhorn JA, Ayala GE, Rowley DR. Reactive stroma in prostate cancer progression. J Urol 2001; 166: 2472-83.
18. Hofer DR, Sherwood ER, Bromberg WD, Mendelsohn J, Lee C, Kozlowski JM. Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha. Cancer Res 1991; 51: 2780-5.
19. Parrondo R, de las Pozas A, Reiner T, Rai P, Perez-Stable C. NF-kappaB activation enhances cell death by antimitotic drugs in human prostate cancer cells. Mol Cancer 2010; 9: 182.
20. Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev 2004; 25: 276-308.
21. Lu X, Yang C, Hill R, Yin C, Hollander MC, Fornace AJ Jr, Van Dyke T. Inactivation of gadd45a sensitizes epithelial cancer cells to ionizing radiation in vivo resulting in prolonged survival. Cancer Res 2008; 68: 3579-83.
22. Guémar L, de Santa Barbara P, Vignal E, Maurel B, Fort P, Faure S. The small GTPase RhoV is an essential regulator of neural crest induction in Xenopus. Dev Biol 2007; 310: 113-28.
23. Bi X, He H, Ye Y, Dai Q, Han Z, Liang Y, Zhong W. Association of TMPRSS2 and KLK11 gene expression levels with clinical progression of human prostate cancer. Med Oncol 2010; 27: 145-51.
24. Cao H, van der Veer E, Ban MR et al. Promoter polymorphism in PCK1 (phosphoenolpyruvate carboxykinase gene) associated with type 2 diabetes mellitus. J Clin Endocrinol Metab 2004; 89: 898-903.